2023-08-08 17:35:58 ET
- Catalyst Pharmaceuticals ( NASDAQ: CPRX ) is scheduled to announce Q2 earnings results on Wednesday, August 9th, after market close.
- The consensus EPS Estimate is $0.29 (+3.6% Y/Y) and the consensus Revenue Estimate is $91.71M (+72.7% Y/Y).
- Over the last 2 years, CPRX has beaten EPS estimates 100% of the time and has beaten revenue estimates 88% of the time.
- Over the last 3 months, EPS estimates have seen 0 upward revisions and 3 downward. Revenue estimates have seen 1 upward revision and 3 downward.
For further details see:
Catalyst Pharmaceuticals Q2 2023 Earnings Preview